A comprehensive review of genetic association studies
暂无分享,去创建一个
[1] N. Risch. Searching for genetic determinants in the new millennium , 2000, Nature.
[2] Johan Auwerx,et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity , 1998, Nature Genetics.
[3] E S Lander,et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. , 2000, Nature genetics.
[4] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[5] Freely associating , 1999, Nature Genetics.
[6] M. Daly,et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.
[7] K. Clément,et al. The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes , 2000, International Journal of Obesity.
[8] K. Marder,et al. The APOE- (cid:101) 4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics , 2001 .
[9] B. Dahlbäck,et al. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[10] T. Kadowaki,et al. The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes , 2000 .
[11] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[12] D. Altshuler,et al. Genetic polymorphisms and disease. , 1998, The New England journal of medicine.
[13] O. Gureje,et al. Lack of an association between apolipoprotein E ϵ4 and Alzheimer's disease in elderly nigerians , 1995 .
[14] M. Norusis,et al. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. , 1991, American journal of human genetics.
[15] M. Kasuga,et al. The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. , 2001, Diabetes.
[16] G. Morgan,et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Margaglione,et al. The Methylenetetrahydrofolate Reductase TT677 Genotype Is Associated with Venous Thrombosis Independently of the Coexistence of the FV Leiden and the Prothrombin , 1998, Thrombosis and Haemostasis.
[18] R. Matthews,et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.
[19] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[20] W. Ewens,et al. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.
[21] N E Morton,et al. Tests and estimates of allelic association in complex inheritance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] E. Lander,et al. Genetic dissection of complex traits science , 1994 .
[23] M. den Heyer,et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida , 1995, The Lancet.
[24] O. Gureje,et al. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. , 1995, Annals of neurology.
[25] P. Reitsma,et al. Thermolabile Methylenetetrahydrofolate Reductase and Factor V Leiden in the Risk of Deep-Vein Thrombosis , 1998, Thrombosis and Haemostasis.
[26] D. Reich,et al. Detecting association in a case‐control study while correcting for population stratification , 2001, Genetic epidemiology.
[27] B. Dahlbäck,et al. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene. , 1996, The Biochemical journal.
[28] D. Steinberg,et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[29] W. Willett,et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. , 1996, Circulation.
[30] V. Colantuoni,et al. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. , 1999, Diabetes.
[31] L. Cardon,et al. Association study designs for complex diseases , 2001, Nature Reviews Genetics.
[32] P. Frosst,et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. , 1996, American journal of human genetics.
[33] J. Pritchard,et al. Use of unlinked genetic markers to detect population stratification in association studies. , 1999, American journal of human genetics.
[34] A. Chakravarti. Population genetics—making sense out of sequence , 1999, Nature Genetics.
[35] A. Evans,et al. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. , 1996, Circulation.
[36] W. Willett,et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. , 1997, Cancer research.
[37] D. Weatherall,et al. The Principles of Human Biochemical Genetics , 1975 .
[38] J. Burn,et al. Susceptibility to spina bifida; an association study of five candidate genes , 1998, Annals of human genetics.
[39] F. Collins,et al. The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. , 2001, Diabetes.
[40] J F Gregory,et al. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. , 1999, The Journal of nutrition.
[41] J. Auwerx,et al. Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus , 2000, International Journal of Obesity.
[42] D C Shields,et al. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. , 1995, QJM : monthly journal of the Association of Physicians.
[43] S. Engeli,et al. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus. , 1999, Biochemical and biophysical research communications.
[44] K. Roeder,et al. Genomic Control for Association Studies , 1999, Biometrics.
[45] P. Donnelly,et al. Association mapping in structured populations. , 2000, American journal of human genetics.
[46] T. Kadowaki,et al. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. , 2000, Biochemical and biophysical research communications.
[47] N. Wenger,et al. Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. , 1998, The Journal of laboratory and clinical medicine.